Over the past few years, increasing interest in the role of autoantibodies against myelin
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating …

Pediatric-onset multiple sclerosis (POMS) is a rare neuroinflammatory and
neurodegenerative disease that has a significant impact on long-term physical and cognitive …

Background and Objective The spectrum of myelin oligodendrocyte glycoprotein (MOG)
antibody–associated disorder (MOGAD) comprises monophasic diseases such as acute …

Background Down syndrome regression disorder is a symptom cluster consisting of
neuropsychiatric regression without cause. This study evaluated the incidence of …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
immune-mediated inflammatory demyelinating disease of the central nervous system. This …

Abstract Aquaporin-4 (AQP4)-IgG seropositive neuromyelitis optica spectrum disorders
(AQP4-IgG seropositive NMOSD) and myelin oligodendrocyte glycoprotein (MOG)–IgG …

Acute disseminated encephalomyelitis (ADEM) is an immune-mediated, inflammatory
demyelinating disease of the central nervous system (CNS) that usually affects children and …

Although there is a substantial amount of data on the clinical characteristics, diagnostic
criteria, and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) autoantibody …

There is increasing knowledge on the role of antibodies against myelin oligodendrocyte
glycoprotein (MOG-abs) in acquired demyelinating syndromes and autoimmune …

PURPOSE OF REVIEW Anti–myelin oligodendrocyte glycoprotein (MOG) autoantibodies
have become a recognized cause of a pathophysiologically distinct group of central nervous …